Dry eye disease and glaucoma both increase in prevalence with age. They are also commonly present in the patient who presents for cataract surgery.
In addition, while DED is not a causative factor for glaucoma, it significantly affects the success of our treatment with topical drops, as patients who have DED signs and symptoms exacerbated by their glaucoma therapy are often less adherent to their medication regimen.
The preservative benzalkonium chloride (BAK), while highly effective in retaining sterility of a solution in the bottle, is quite toxic to the epithelium, (Read more...)
Uncategorized